• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Ophthalmology

Binocular eye tracking-based device is non-inferior to patching for the treatment of amblyopia

byMolly Munsell
November 3, 2022
in 2 Minute Medicine, Ophthalmology, Pediatrics
Reading Time: 3 mins read
Eye disease collage: a close-up of one eye, round wire-rimmed glasses, an ophthalmoscope and a cross-section of the eyeball
Share on FacebookShare on TwitterShare on LinkedIn

1. In a small randomized controlled trial, children with amblyopia who used a newly developed binocular dichoptic home device had similar visual acuity at 16 weeks to children whose dominant eye was patched.

2. Treatment adherence was significantly higher in the device group than the patching group, at 91% compared to 83%.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Amblyopia is a common disorder in which vision is poorer in one eye due to abnormalities during visual development, such as uneven refractive error or strabismus. It is traditionally treated with monocular therapy, penalizing the dominant eye with patches or dilating drops, but in recent years, several new binocular treatment methods have been developed. Children are presented with dichoptic (separate for each eye) images that are blurred in the dominant eye while stimulating the amblyopic eye. This study aimed to assess the efficacy of one such device, CureSight, compared to patching. A total of 103 patients with amblyopia were randomized to treatment with CureSight or patching for 16 weeks. At week 16, visual acuity in the amblyopic eye had significantly improved in both groups, by 0.28±0.13 logMAR units in the CureSight group and 0.23±0.14 in the patching group, meeting the primary endpoint of non-inferiority. Visual acuity in the majority of patients in both groups improved by 2 lines or more. Stereoacuity, representing use of both eyes, also improved significantly in both groups but did not differ between groups. Adherence to treatment based on total treatment time was 91% in the CureSight group and 83% in the patching group. This small randomized trial convincingly showed non-inferiority to patching, making the CureSight device one of the most rigorously studied of the recently developed binocular treatment systems and therefore a useful new treatment option. While adherence was significantly higher with the device, however, it is far more expensive and complex to implement than patching without showing superior visual acuity or stereoacuity outcomes at 16 weeks.

Click to read the study in Ophthalmology

Relevant Reading: Recent advances in screening and treatment for amblyopia

RELATED REPORTS

Optogenetic therapy may partially restore vision in retinitis pigmentosa

Tenecteplase not associated with visual improvement in central retinal artery occlusion

In-Depth [randomized controlled trial]: Children aged 4 to 9 at multiple centers in Israel with best corrected visual acuity between 20/32 and 20/100 in the amblyopic eye were randomized 1:1, then treated between 2020 and 2022. Patients with amblyopia due to large angle strabismus or changes in prescription in the previous 16 weeks were excluded. Children in the CureSight group watched videos on a computer through glasses that selectively blurred central vision in the dominant eye based on input from an eye tracker. CureSight treatment was for 90 minutes, 5 days per week, while patching was for 2 hours, 7 days per week. About half of patients had previously undergone patching, while half had never been treated. The primary non-inferiority outcome was based on a modified intention-to-treat analysis, but visual acuity difference did not significantly differ in a per-protocol analysis either. The difference between CureSight and patching groups in least-squares mean improvement in amblyopic-eye visual acuity at 16 weeks was 0.034 logMAR units, with a 90% confidence interval (CI) of -0.008 to 0.076, less than the pre-defined non-inferiority margin of -0.10 logMAR units. The difference between groups in change in stereoacuity was 0, with a 95% CI of -0.27 to 0.27 (p=0.76). The difference in binocular visual acuity improvement at 16 weeks was also not significant.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: deviceLazy Eye (Amblyopia)visionvisual acuity
Previous Post

#VisualAbstract: Lower oxygen saturation does not improve survival in cardiac arrest patients

Next Post

Glycopyrrolate not associated with decreased vasopressor use for cesarean deliveries

RelatedReports

A woman using a red light therapy device while seated, surrounded by workout equipment and papers, suggesting engagement in wellness practices.
Chronic Disease

Optogenetic therapy may partially restore vision in retinitis pigmentosa

October 23, 2026
Blood clots collage: a cutaway vein where a fibrin mesh unravels among red blood cells, an engraved eye and a pill bottle
Neurology

Tenecteplase not associated with visual improvement in central retinal artery occlusion

January 28, 2026
Ischemic stroke collage: an engraved brain with one artery traced in blue beside a glass hourglass on graph paper
Chronic Disease

Personalized visual perceptual learning digital therapy may improve vision post-stroke

May 30, 2025
Eye disease collage: an engraved slit-lamp microscope casting a pale beam, with folded reading glasses on graph paper
Pharma

Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease

January 31, 2025
Next Post

Glycopyrrolate not associated with decreased vasopressor use for cesarean deliveries

Differences amongst eating disorder diagnoses should be considered in effective management

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In a randomized sham-controlled trial, acupoint thread embedding produced a between-group difference in change from baseline of 1.8 kg at 12 weeks and 3.0 kg at 24 weeks in Chinese women with overweight or obesity
  • PROT-001 was generally safe and well tolerated in a phase 1 study of healthy volunteers with AL amyloidosis
  • 2MM: AI Roundup- PTSD Prediction, Gait as a Biomarker, Faster Cardiac MRI, and Perinatal Mental Health Chatbots [November 12th, 2026]
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.